Found 39 matching trials
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females PHASE3 This study is designed to evaluate the vaccine efficacy, immunogenicity and...
Show More Location
Liuzhou center for disease control and prevention
Learn More & Join Trial
Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066) PHASE3 The primary objective of this study is the estimation of the human papillom...
Show More Location
Sotobo Children's Clinic ( Site 6616)
Learn More & Join Trial
Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) PHASE3 This study will evaluate the efficacy, immunogenicity and safety of 9-valen...
Show More Status
Active Not Recruiting
Location
Lingchuan Center for Disease Control and Prevention ( Site 0002)
Learn More & Join Trial
A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004) PHASE1 Researchers are looking for new ways to prevent cancers related to human pa...
Show More Status
Active Not Recruiting
Location
Research Centers of America ( Hollywood ) ( Site 0001)
Learn More & Join Trial
A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213) PHASE3 This study is designed to evaluate the immunogenicity, safety, and tolerabi...
Show More Location
Yangchun Center For Disease Prevention And Control ( Site 0003)
Learn More & Join Trial
Safety and Immunogenicity of V540B in Healthy Adults (V540B-002). PHASE1 Researchers are looking for new ways to prevent cancers related to human pa...
Show More Status
Active Not Recruiting
Location
Anaheim Clinical Trials ( Site 0002)
Learn More & Join Trial
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females PHASE3 The study will evaluate the immunogenicity and safety of 9-valent HPV recom...
Show More Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Learn More & Join Trial
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini PHASE4 This is a multi-site, open-label non-inferiority study of the 9vHPV vaccine...
Show More Learn More & Join Trial
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts PHASE3 Cutaneous viral warts are very common and are caused by the human papilloma...
Show More Learn More & Join Trial
Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 PHASE3 This study will evaluate the immunogenicity and safety of Zerun 9-valent HP...
Show More Location
GuangXi Center for Diseases Control and Prevention
Learn More & Join Trial